These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1493524)

  • 21. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A
    Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel vaccines and adjuvants for allergen-specific immunotherapy.
    Crameri R; Rhyner C
    Curr Opin Immunol; 2006 Dec; 18(6):761-8. PubMed ID: 17010585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of atopic rhinitis in children with an accelerated variant of specific immunotherapy].
    Gamzatova AA; Gadzhimirzaev GA
    Vestn Otorinolaringol; 1994; (5-6):33-7. PubMed ID: 7856017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current aspects of diagnosis and treatment of atopic diseases complicated by secondary immunodeficiency].
    Mikheeva GN; Khaitov RM
    Ter Arkh; 1998; 70(4):54-60. PubMed ID: 9612905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopharmacology.
    Terezhalmy GT; Esposito SJ; Safadi GS
    Dent Clin North Am; 1996 Jul; 40(3):685-707. PubMed ID: 8829051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New therapeutic methods in the treatment of multiple sclerosis].
    Nervenarzt; 1996 Nov; 67(11 Suppl Neue Ther):1-12. PubMed ID: 9402424
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 29. [What can one expect of immunostimulants in the clinical setting?].
    Bach JF
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):233-6. PubMed ID: 3539497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective study of specific immunotherapy - what should be done in the future.
    Milavec-Puretić V; Lipozencić J; Ledić-Drvar D; Smigovec E; Milavec D
    Acta Dermatovenerol Croat; 2007; 15(4):221-7. PubMed ID: 18093449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of specific immunotherapy technics in immediate hypersensitivity].
    Dry J
    Bull Acad Natl Med; 1983; 167(7):731-5. PubMed ID: 6365259
    [No Abstract]   [Full Text] [Related]  

  • 32. Feline immunotherapy.
    Trimmer AM; Griffin CE; Rosenkrantz WS
    Clin Tech Small Anim Pract; 2006 Aug; 21(3):157-61. PubMed ID: 16933483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological mechanism of desensitization treatment of atopic diseases].
    Kujawa H
    Postepy Hig Med Dosw; 1980; 34(4):321-38. PubMed ID: 6170055
    [No Abstract]   [Full Text] [Related]  

  • 34. The status of immunotherapy in children--what are the problems?
    Collins-Williams C
    Ann Allergy; 1977 Aug; 39(2):87-93. PubMed ID: 329719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of specific immunotherapy on the structural properties of the lymphocyte membranes in atopic diseases].
    Cherkashin SIu; Nagornaia IN; Tananko EM; Dymshits LB; Nosikova TA
    Ter Arkh; 1989; 61(7):95-7. PubMed ID: 2588151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glatiramer acetate therapy: the plot thickens.
    Karandikar NJ; Racke MK
    Arch Neurol; 2005 Jun; 62(6):858-9. PubMed ID: 15956155
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunoactive peptides in chronic polyarthritis].
    Internist (Berl); 1994 Mar; 35(3 Suppl):1-8. PubMed ID: 9211665
    [No Abstract]   [Full Text] [Related]  

  • 39. Salivary IgA levels in atopic children.
    Payette K; Weiss NS
    Ann Allergy; 1977 Nov; 39(5):328-31. PubMed ID: 920998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glatiramer and suspected multiple sclerosis. No proven advantage.
    Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.